Bryan Cave Leighton Paisner’s Moscow office has advised Teva on the sale of a pharmaceutical company located in the Yaroslavl Industrial Park to Russia’s R-Pharm Group.
Teva is an American-Israeli producer of pharmaceuticals that was founded in 1901. The company operates facilities across Europe, North and South America, and Australia.
According to BCLP, “the plant produces drugs intended for the treatment of diseases in the field of cardiology and neurology, as well as diseases of the endocrine system.” BCLP also stated that the terms of the sale, “include a five-year agreement during which R-Pharm will act as Teva's manufacturing partner to ensure patient access to Teva's drugs.”
BCLP’s team consisted of Partners Vitaly Mozharovsky and Matvey Kaploukhoy, Counsels Oksana Orlovskaya, Inna Firsova, and Vladislav Vdovin, Associate Mikhail Erokhin, and Junior Associate Elena Naumova.
BCLP could not disclose further information about the deal.
